Skeletal Radiology

, Volume 41, Issue 8, pp 887–897 | Cite as

Advanced imaging of skeletal manifestations of systemic mastocytosis

  • J. Fritz
  • E. K. Fishman
  • J. A. Carrino
  • M. S. Horger
Review Article

Abstract

Systemic mastocytosis comprises a group of clonal disorders of the mast cell that most commonly involves the skeletal system. Imaging can be helpful in the detection and characterization of the osseous manifestations of this disease. While radiography and bone scans are frequently used for this assessment, low-dose multidetector computed tomography and magnetic resonance imaging can be more sensitive for the detection of marrow involvement and for the demonstration of the various disease patterns. In this article, we review the pathophysiological and clinical features of systemic mastocytosis, discuss the role of imaging for staging and management, and illustrate the various cross-sectional imaging appearances. Awareness and knowledge of the imaging features of this disorder will increase the accuracy of image interpretation and can contribute important information for management decisions.

Keywords

Mastocytosis Computed tomography Magnetic resonance imaging Diffusion-weighted imaging Staging 

Notes

Conflict of interest

The authors declare that they have no conflict of interest.

Grants

None.

References

  1. 1.
    Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood. 1999;94:2333–42.PubMedGoogle Scholar
  2. 2.
    Marshall JS, Jawdat DM. Mast cells in innate immunity. J Allergy Clin Immunol. 2004;114:21–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Horny H, Metcalfe D, Bennett J, Bain B, Akin C, Escribano L. Mastocytosis. In: Swerdlow S, Campo E, Harris N, editors. WHO classification of tumors of hematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 54–63.Google Scholar
  4. 4.
    Valent P, Sperr WR, Schwartz LB, Horny HP. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. J Allergy Clin Immunol. 2004;114:3–11.PubMedCrossRefGoogle Scholar
  5. 5.
    Murali MR, Castells MC, Song JY, Dudzinski DM, Hasserjian RP. Case records of the Massachusetts General Hospital. Case 9-2011. A 37-year-old man with flushing and hypotension. N Engl J Med. 2011;364:1155–65.PubMedCrossRefGoogle Scholar
  6. 6.
    Zanotti R, Bonadonna P, Bonifacio M, Artuso A, Schena D, Rossini M, et al. Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis. Haematologica. 2011;96:482–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Simpson JK, Metcalfe DD. Mastocytosis and disorders of mast cell proliferation. Clin Rev Allergy Immunol. 2002;22:175–88.PubMedCrossRefGoogle Scholar
  8. 8.
    Akin C, Metcalfe DD. Systemic mastocytosis. Annu Rev Med. 2004;55:419–32.PubMedCrossRefGoogle Scholar
  9. 9.
    Travis WD, Li CY, Bergstralh EJ, Yam LT, Swee RG. Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine (Baltimore). 1988;67:345–68.Google Scholar
  10. 10.
    Genovese A, Spadaro G, Triggiani M, Marone G. Clinical advances in mastocytosis. Int J Clin Lab Res. 1995;25:178–88.PubMedCrossRefGoogle Scholar
  11. 11.
    Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603–25.PubMedCrossRefGoogle Scholar
  12. 12.
    Pardanani A, Lim KH, Lasho TL, Finke C, McClure RF, Li CY, et al. Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies. Blood. 2009;114:3769–72.PubMedCrossRefGoogle Scholar
  13. 13.
    Parker RI. Hematologic aspects of systemic mastocytosis. Hematol Oncol Clin North Am. 2000;14:557–68.PubMedCrossRefGoogle Scholar
  14. 14.
    Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood. 2009;113:5727–36.PubMedCrossRefGoogle Scholar
  15. 15.
    Barete S, Assous N, de Gennes C, Grandpeix C, Feger F, Palmerini F, et al. Systemic mastocytosis and bone involvement in a cohort of 75 patients. Ann Rheum Dis. 2010;69:1838–41.PubMedCrossRefGoogle Scholar
  16. 16.
    Lawrence JB, Friedman BS, Travis WD, Chinchilli VM, Metcalfe DD, Gralnick HR. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. Am J Med. 1991;91:612–24.PubMedCrossRefGoogle Scholar
  17. 17.
    Johansson C, Roupe G, Lindstedt G, Mellstrom D. Bone density, bone markers and bone radiological features in mastocytosis. Age Ageing. 1996;25:1–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Rafii M, Firooznia H, Golimbu C, Balthazar E. Pathologic fracture in systemic mastocytosis. Radiographic spectrum and review of the literature. Clin Orthop Relat Res. 1983;260–7.Google Scholar
  19. 19.
    Rosenbaum RC, Frieri M, Metcalfe DD. Patterns of skeletal scintigraphy and their relationship to plasma and urinary histamine levels in systemic mastocytosis. J Nucl Med. 1984;25:859–64.PubMedGoogle Scholar
  20. 20.
    Goldhaber P. Heparin enhancement of factors stimulating bone resorption in tissue culture. Science. 1965;147:407–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Griffith GC, Nichols Jr G, Asher JD, Flanagan B. Heparin osteoporosis. JAMA. 1965;193:91–4.PubMedCrossRefGoogle Scholar
  22. 22.
    Gospodarowicz D, Cheng J. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol. 1986;128:475–84.PubMedCrossRefGoogle Scholar
  23. 23.
    McKenna MJ, Frame B. The mast cell and bone. Clin Orthop Relat Res. 1985;226–33.Google Scholar
  24. 24.
    Resnick D, Haghishi P. Lymphoproliferative and myeloproliferative disorders. In: Resnick D, editor. Diagnosis of bone and joint disorders. Philadelphia: Saunders; 2002. p. 2327–31.Google Scholar
  25. 25.
    Floman Y, Amir G. Systemic mastocytosis presenting with severe spinal osteopenia and multiple compression fractures. J Spinal Disord. 1991;4:369–73.PubMedCrossRefGoogle Scholar
  26. 26.
    Anil G, Guglielmi G, Peh WC. Radiology of osteoporosis. Radiol Clin N Am. 2010;48:497–518.PubMedCrossRefGoogle Scholar
  27. 27.
    Sundaram M. Founders lecture 2007: Metabolic bone disease: what has changed in 30 years? Skeletal Radiol. 2009;38:841–53.PubMedCrossRefGoogle Scholar
  28. 28.
    Link TM. The Founder’s Lecture 2009: advances in imaging of osteoporosis and osteoarthritis. Skeletal Radiol. 2010;39:943–55.PubMedCrossRefGoogle Scholar
  29. 29.
    Ejindu VC, Hine AL, Mashayekhi M, Shorvon PJ, Misra RR. Musculoskeletal manifestations of sickle cell disease. Radiographics. 2007;27:1005–21.PubMedCrossRefGoogle Scholar
  30. 30.
    Katz R, Booth T, Hargunani R, Wylie P, Holloway B. Radiological aspects of Gaucher disease. Skeletal Radiol. 2011;40:1505–13.PubMedCrossRefGoogle Scholar
  31. 31.
    Sebes JI, Niell HB, Palmieri GM, Reidy TJ. Skeletal surveys in multiple myeloma. Radiologic-clinical correlation. Skeletal Radiol. 1986;15:354–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Horger M, Kanz L, Denecke B, Vonthein R, Pereira P, Claussen CD, et al. The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma. Cancer. 2007;109:1617–26.PubMedCrossRefGoogle Scholar
  33. 33.
    Tunaci M, Tunaci A, Engin G, Ozkorkmaz B, Dincol G, Acunas G, et al. Imaging features of thalassemia. Eur Radiol. 1999;9:1804–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Bieler EU, Wohlenberg H, Utech C. Skeletal manifestations of generalized mastocytosis in the skeletal scintigram compared with roentgen findings. Rofo. 1985;142:552–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Huang TY, Yam LT, Li CY. Radiological features of systemic mast-cell disease. Br J Radiol. 1987;60:765–70.PubMedCrossRefGoogle Scholar
  36. 36.
    Bancroft LW, Berquist TH. Erdheim-Chester disease: radiographic findings in five patients. Skeletal Radiol. 1998;27:127–32.PubMedCrossRefGoogle Scholar
  37. 37.
    Baskin Jr HJ. The pathogenesis and imaging of the tuberous sclerosis complex. Pediatr Radiol. 2008;38:936–52.PubMedCrossRefGoogle Scholar
  38. 38.
    Guermazi A, de Kerviller E, Cazals-Hatem D, Zagdanski AM, Frija J. Imaging findings in patients with myelofibrosis. Eur Radiol. 1999;9:1366–75.PubMedCrossRefGoogle Scholar
  39. 39.
    Mithal A, Trivedi N, Gupta SK, Kumar S, Gupta RK. Radiological spectrum of endemic fluorosis: relationship with calcium intake. Skeletal Radiol. 1993;22:257–61.PubMedCrossRefGoogle Scholar
  40. 40.
    Mirra JM, Brien EW, Tehranzadeh J. Paget’s disease of bone: review with emphasis on radiologic features. II. Skeletal Radiol. 1995;24:173–84.PubMedGoogle Scholar
  41. 41.
    Mirra JM, Brien EW, Tehranzadeh J. Paget’s disease of bone: review with emphasis on radiologic features. I. Skeletal Radiol. 1995;24:163–71.PubMedGoogle Scholar
  42. 42.
    Burgener FA, Perry PE. Solitary renal cell carcinoma metastasis in Paget’s disease simulating sarcomatous degeneration. AJR Am J Roentgenol. 1977;128:853–5.PubMedGoogle Scholar
  43. 43.
    Dell’Atti C, Cassar-Pullicino VN, Lalam RK, Tins BJ, Tyrrell PN. The spine in Paget’s disease. Skeletal Radiol. 2007;36:609–26.PubMedCrossRefGoogle Scholar
  44. 44.
    Sundaram M. Renal osteodystrophy. Skeletal Radiol. 1989;18:415–26.PubMedCrossRefGoogle Scholar
  45. 45.
    Graves III L, Stechschulte DJ, Morris DC, Lukert BP. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes. J Bone Miner Res. 1990;5:1113–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Chen CC, Andrich MP, Mican JM, Metcalfe DD. A retrospective analysis of bone scan abnormalities in mastocytosis: correlation with disease category and prognosis. J Nucl Med. 1994;35:1471–5.PubMedGoogle Scholar
  47. 47.
    Ho LM, Lipper MH. Mastocytosis of the axial skeleton presenting as an epidural mass lesion: MR imaging appearance. AJR Am J Roentgenol. 1996;167:716–8.PubMedGoogle Scholar
  48. 48.
    Gleeson TG, Moriarty J, Shortt CP, Gleeson JP, Fitzpatrick P, Byrne B, et al. Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI). Skeletal Radiol. 2009;38:225–36.PubMedCrossRefGoogle Scholar
  49. 49.
    Kropil P, Fenk R, Fritz LB, Blondin D, Kobbe G, Modder U, et al. Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma. Eur Radiol. 2008;18:51–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Mahnken AH, Wildberger JE, Gehbauer G, Schmitz-Rode T, Blaum M, Fabry U, et al. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. AJR Am J Roentgenol. 2002;178:1429–36.PubMedGoogle Scholar
  51. 51.
    Avila NA, Ling A, Metcalfe DD, Worobec AS. Mastocytosis: magnetic resonance imaging patterns of marrow disease. Skeletal Radiol. 1998;27:119–26.PubMedCrossRefGoogle Scholar
  52. 52.
    Avila NA, Ling A, Worobec AS, Mican JM, Metcalfe DD. Systemic mastocytosis: CT and US features of abdominal manifestations. Radiology. 1997;202:367–72.PubMedGoogle Scholar
  53. 53.
    Horger M, Claussen CD, Bross-Bach U, Vonthein R, Trabold T, Heuschmid M, et al. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography. Eur J Radiol. 2005;54:289–97.PubMedCrossRefGoogle Scholar
  54. 54.
    Roca M, Mota J, Giraldo P, Garcia Erce JA. Systemic mastocytosis: MRI of bone marrow involvement. Eur Radiol. 1999;9:1094–7.PubMedCrossRefGoogle Scholar
  55. 55.
    Haney K, Russell W, Raila FA, Brower AC, Harrison RB. MRI characteristics of systemic mastocytosis of the lumbosacral spine. Skeletal Radiol. 1996;25:171–3.PubMedCrossRefGoogle Scholar
  56. 56.
    Hwang S, Panicek DM. Magnetic resonance imaging of bone marrow in oncology. I. Skeletal Radiol. 2007;36:913–20.PubMedCrossRefGoogle Scholar
  57. 57.
    Khoo MM, Tyler PA, Saifuddin A, Padhani AR. Diffusion-weighted imaging (DWI) in musculoskeletal MRI: a critical review. Skeletal Radiol. 2011;40:665–81.PubMedCrossRefGoogle Scholar
  58. 58.
    Bartuseviciene A, Samuilis A, Skucas J. Camurati-Engelmann disease: imaging, clinical features and differential diagnosis. Skeletal Radiol. 2009;38:1037–43.PubMedCrossRefGoogle Scholar
  59. 59.
    Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skeletal Radiol. 2007;36:1109–19.PubMedCrossRefGoogle Scholar
  60. 60.
    Chavhan GB, Babyn PS. Whole-body MR imaging in children: principles, technique, current applications, and future directions. Radiographics. 2011;31:1757–72.PubMedCrossRefGoogle Scholar
  61. 61.
    Bauerle T, Hillengass J, Fechtner K, Zechmann CM, Grenacher L, Moehler TM, et al. Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging. Radiology. 2009;252:477–85.PubMedCrossRefGoogle Scholar
  62. 62.
    Zettinig G, Becherer A, Szabo M, Uffmann M, Dudczak R, Valent P, et al. FDG positron emission tomography in patients with systemic mastocytosis. AJR Am J Roentgenol. 2002;179:1235–7.PubMedGoogle Scholar
  63. 63.
    Tomihama RT, McEachen JC, Kuo PH. Imaging of systemic mastocytosis by FDG-PET/CT demonstrates increased activity in cortical bone. Clin Nucl Med. 2008;33:220–3.PubMedCrossRefGoogle Scholar

Copyright information

© ISS 2012

Authors and Affiliations

  • J. Fritz
    • 1
    • 3
  • E. K. Fishman
    • 1
  • J. A. Carrino
    • 1
  • M. S. Horger
    • 2
  1. 1.Russell H. Morgan Department of Radiology and Radiological ScienceJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Department of Diagnostic and Interventional RadiologyEberhard-Karls-UniversityTübingenGermany
  3. 3.Russell H. Morgan Department of Radiology and Radiological ScienceJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations